Tau: a novel target to prevent early neuronal dysfunction and death in glaucoma.

Tau：预防青光眼早期神经元功能障碍和死亡的新靶点。

• 批准号: 356356
• 负责人: Di Polo Adriana
• 金额: $ 65.2万
• 依托单位: Universit de Montral
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=356356&lang=en
• 关键词: Alzheimer'S Disease; Dendrite Pathology; Glaucoma; Optic Nerve Pathology; Retina; Retinal Degeneration; Retinal Ganglion Cell; Tau

Sight is essential for humans to gather critical information about their surroundings. The fear of going blind has been reported to be more powerful than that of having cancer or heart disease. Glaucoma is the leading cause of irreversible blindness, affe

视觉对于人类收集周围环境的重要信息至关重要。据报道，对失明的恐惧比对癌症或心脏病的恐惧更强烈。青光眼是导致不可逆性失明的主要原因